PLAY PODCASTS
Talking Biotech with Dr. Kevin Folta

Talking Biotech with Dr. Kevin Folta

Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering.

Colabra · Kevin Folta

502 episodesEN-US

Show overview

Talking Biotech with Dr. Kevin Folta has been publishing since 2015, and across the 11 years since has built a catalogue of 502 episodes, alongside 2 trailers or bonus episodes. That works out to roughly 360 hours of audio in total. Releases follow a weekly cadence.

Episodes typically run thirty-five to sixty minutes — most land between 34 min and 49 min — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-US-language Science show.

The show is actively publishing — the most recent episode landed 4 days ago, with 23 episodes already out so far this year. Published by Kevin Folta.

Episodes
502
Running
2015–2026 · 11y
Median length
40 min
Cadence
Weekly

From the publisher

Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.

Latest Episodes

View all 502 episodes

Gates Ag One-Technology Development for Smallholder Farmers in Africa and South Asia

Oct 5, 202628 min

The Story of Oncolytic Viruses to Cure Cancer Tumors!

Sep 28, 202631 min

The history & science behind GLP1 receptor agonists

Aug 31, 202643 min

Meat Proteins in Plants

Aug 24, 202631 min

New Strategies in Early ALS Detection

Aug 17, 202642 min

A new strategy in the war on obesity

Aug 6, 202630 min

Cameron English-The Debate on Conventional vs Organic Farming

Jul 29, 202647 min

Stop Political Interference in Federal Science Grants! With Dr. Colette Delawalla

Jul 3, 202656 min

The Future of Agriculture -- Dr. Scott Angle

Jun 29, 202659 min

Biotech Mold Detection and Health - Brian Karr

Jun 23, 202638 min

Dr. Neil Stewart-Radiation Sensing Potatoes

Jun 16, 202624 min

Milk Proteins without the Dairy - Adam Tarshis and Dr. Cory Tobin

Jun 9, 202650 min

New Technology in Severe Burn Care - Dr. Katie Bush

Jun 1, 202631 min

New Methods in Early Cancer Detection - Dr. Nate Montgomery

May 25, 202639 min

Strategies in Combating Chronic Kidney Disease - Dr. Salvadore Viscomi

May 17, 202640 min

AI and the Future of Healthcare -- Dr. Emilia Javorsky

May 8, 202639 min

The First Environmental GE Organism Release - almost! Dr. Steven Lindow

Apr 28, 202625 min

New Frontiers in Therapeutic Peptides - Dr. Karsten Eastman

Apr 16, 202633 min

Ep 490Genetic Variation in Vegetative Propagation - Dr. Danelle Seymour

In this episode of the Talking Biotech podcast, Dr. Danelle Seymour discusses the genetic anomoliies observed in the vegetative propagation of tree crops, particularly citrus. The conversation delves into the importance of preserving genetic material through grafting, the challenges of genetic variation in vegetatively propagated plants, and the role of mutations in these processes. Dr. Seymour shares insights from her research on the historic Washington Naval orange tree and the implications of somatic mutations for breeding and disease resistance in citrus.

Apr 1, 202628 min

Ep 489Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh

In this episode of the Talking Biotech podcast, Dr. Kevin Folta speaks with Dr. Neela Patel and Dr. Diane Hollenbaugh from Bonum Therapeutics about the emerging field of conditionally active biologics. They discuss the challenges of current therapies, the innovative mechanisms behind their drug development, and the potential of immuno-oncology to revolutionize cancer treatment. The conversation also covers the market landscape, the origin story of Bonum, and the future directions for their pipeline, emphasizing the importance of targeted therapies in improving patient outcomes.

Feb 27, 202646 min
© 2026 Colabra